Glass contamination prompts Fresenius recall
July 4, 2013Manufacturing and Production Fresenius, recall
The US subsidiary of German drugmaker Fresenius has recalled a drug used in the treatment of Parkinson’s disease because of …
ICON appoints chief medical officer
July 4, 2013Manufacturing and Production, Research and Development, Sales and Marketing EMA, ICON, buckley
Clinical research organisation ICON has confirmed the appointment of Professor Brendan Buckley as chief medical officer. Buckley will be ICON’s …
Roche leukaemia drug granted speedy US review
July 3, 2013Research and Development, Sales and Marketing CLL, FDA, Roche, leukaemia, obinutuzumab
Roche’s investigational leukaemia drug could be available for US patients by the end of the year as the FDA looks …
FDA gives Perjeta priority
July 3, 2013Sales and Marketing FDA, Perjeta, Roche, breast cancer
The FDA has granted priority review status to an application for Roche’s Perjeta to be used before surgery in HER2-positive …
Merck Serono sets up cancer platform
July 3, 2013Research and Development, Sales and Marketing Cancer, Cladribine, Merck Serono, kgaa
Merck Serono is attempting to speed up R&D on products which stimulate the immune system to fight cancer by establishing …
RSA makes series of appointments
July 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing rsa
Life Sciences Executive Search and Interim Management firm RSA has made a series of appointments across the company. Codrina Schech …
EMA approves extended Xaluprine shelf life
July 2, 2013Manufacturing and Production, Research and Development
The European Medicines Agency (EMA) has approved an extension of the in-use shelf life for Xaluprine – a liquid formulation …
VTE boost for Eliquis
July 2, 2013Research and Development, Sales and Marketing AMPLIFY, BMS, DVT, Eliquis, Pfizer
Bristol-Myers Squibb and Pfizer’s oral blood thinner Eliquis is as efficient as standard of care and causes less bleeding in …
China tightens quality standards for pharma distributors
July 2, 2013Manufacturing and Production China, FDA, GMP, GSP
From 1 July new pharmaceutical distributors in China will be obliged to adhere to the country’s recently-issued Good Supply Practice …
Onyx rejects Amgen – seeks new suitors
July 2, 2013Sales and Marketing Amgen, Onyx
Amgen’s advances for Onyx have been knocked back as the biotech firm says it is now seeking new suitors. Onyx …
Roche buys blood testing firm for $220m
July 2, 2013Sales and Marketing CMI, Diagnostics, Roche
Roche has acquired Boston-based Constitution Medical Investors in order to buy into its haematology testing system. The cancer drug specialist …
MSI Consultancy announces three senior appointments
July 2, 2013Medical Communications, Sales and Marketing MSI
Pharma marketing firm The MSI Consultancy has expanded its team with the appointment of three industry marketers as senior consultants. …
FDA has Xarelto concerns
July 2, 2013Sales and Marketing Bayer, Boehringer, FDA, Pradaxa, Xarelto
The FDA is unsure about an application to further extend the licence for Janssen and Bayer HealthCare’s blood thinner Xarelto …
Watermeadow shortlisted for medical education award
July 1, 2013Medical Communications Communique, Excellence in Ophthalmology, UK, Watermeadow Medical, award-winning agency, finalist, medical education, ophthalmology, programme
Watermeadow Medical is delighted that one of its educational programmes has been shortlisted for the ‘Excellence in Professional Education Programmes’ …
Watermeadow’s continued commitment to ethical publications
July 1, 2013Medical Communications CMPP, Medical Writer, Qualification, Watermeadow Medical, Writer, agency, editor, ethical, ethics, medical editor, medical writing, publication specialist, publications
As part of Watermeadow Medical’s commitment to ethical publications, five more of its editorial staff have qualified as Certified Medical …
Remicade copies set for European entry
July 1, 2013Sales and Marketing CHMP, Hospira, Janssen, Remicade, arthritis, biosimilar
Janssen’s Remicade could soon come under generic pressure after a landmark recommendation by the CHMP. South Korean biotech Celltrion and …
Aspen buys Merck facility and products in $1 billion deal
July 1, 2013Manufacturing and Production MSD, Merck, Oss, aspen
Africa’s largest drugmaker Aspen Pharmacare has agreed to buy a manufacturing facility owned by Merck & Co, plus a portfolio …
Ben Adams appointed editor of Pharmafocus
July 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, McConaghie, Pharmafocus
Ben Adams has become the new editor of the monthly Pharmafocus newspaper and the Pharmafile.com website. Adams, formerly the senior …
Sanofi’s Lemtrada nears EU approval
July 1, 2013Sales and Marketing CHMP, Genzyme, Lemtrada, Sanofi
Sanofi’s multiple sclerosis drug Lemtrada has received a positive recommendation from the CHMP, meaning a European approval is likely just …
A call for harmony on clinical trials
July 1, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Frédéric Sgard, OECD, clinical trials
Clinical trials are an essential part of the development of medical treatments. They involve testing new medicines or new therapies, …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
